Charles River Laboratories International CRL
NYSE CRL
$282.06 +8.65 (+3.16%)
As of: Sep 17, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Property, Plant & Equipment (Net) (2009 - 2026)

Analysis

Charles River Laboratories International (CRL) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 547.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 157.11 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 385.43 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 1.49 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 156.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - 522.80 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 157.19 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 3.79 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 2.87 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 189,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 1.49 Bn
Mar 28, 2026 1.51 Bn
Dec 27, 2025 1.66 Bn
Sep 27, 2025 1.59 Bn
Jun 28, 2025 1.61 Bn
Mar 29, 2025 1.59 Bn
Dec 28, 2024 1.60 Bn
Sep 28, 2024 1.64 Bn
Jun 29, 2024 1.61 Bn
Mar 30, 2024 1.62 Bn
Dec 30, 2023 1.64 Bn
Sep 30, 2023 1.53 Bn
Jul 1, 2023 1.53 Bn
Apr 1, 2023 1.49 Bn
Dec 31, 2022 1.47 Bn
Sep 24, 2022 1.38 Bn
Jun 25, 2022 1.38 Bn
Mar 26, 2022 1.32 Bn
Dec 25, 2021 1.29 Bn
Sep 25, 2021 1.18 Bn